Veru

Veru is an oncology biopharmaceutical company focused on developing new drugs for the treatment of breast cancer and prostate cancer. Our strategy is primarily centered on the clinical development and commercialization of oncology drugs to treat the two most prevalent cancers globally—breast cancer and prostate cancer.